ARCHIMED Acquires Majority Stake in ExcellGene and Magellan Biologics & Consulting

Lenz & Staehelin has advised ARCHIMED. Walder Wyss has advised the sellers.ARCHIMED, a global private equity specialist in the healthcare sector, has acquired a majority stake…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here